4 results
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
pharmacotherapy trials in BPD ... following outcomes: BPD ... placebo-controlled Managing BPD ... the UK national BPD ... #BPD #Borderline
Benzodiazepine (BZD) withdrawal: clinical findings and complications

 • Activation of ACC and OFC -> Feelings of
Benzodiazepine (BZD ... Activity -> Incr BP ... Benzodiazepine #BZD ... #withdrawal #pharmacology ... pathophysiology #diagnosis
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
hours or longer/BP ... circulation: MCA ACA ... Electrolyte abnormality, Medication ... patients - 10-25% BP ... overaggressive BP
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
and diuretics all ... Lithium is a medication ... maintenance agent for treatment ... Bipolar #Disorder #BPD ... #Toxicity #Pharmacology